FDA Requires RSV Vaccine Labels to Include Guillain-Barré Syndrome Risk
On Jan. 7, 2025, the U.S. Food and Drug Administration (FDA) mandated and approved changes to the safety labeling for the Prescribing Information of two Respiratory Syncytial Virus (RSV) vaccines: Abrysvo (manufactured by Pfizer)1 and Arexvy (manufactured by GlaxoSmithKline Biologicals).2 This label change update is being required to inform both the public and health care […]
Three German Scientists Call for Immediate Halt on All mRNA Biologicals, Including COVID Shots
German authors of a new peer-reviewed study called for an “immediate halt of all mRNA biologicals,” ” including COVID-19 shots, until questions about residual DNA that well exceeds regulatory limits can be answered. The study, published on Dec. 3, 2024 in the Public Health Policy Journal, underscores concerns about the mRNA technology that includes the […]
Doctors Cash In: The Hidden Profits Behind Pediatric Vaccinations
Healthcare providers for years have been leading the charge in recommending—and often pressuring—parents to vaccinate their children. During the COVID-19 pandemic, strong endorsements from pediatricians played a significant role1 in the acceptance of experimental COVID-19 shots for kids, while parents expressed dismay at receiving dismissal letters for delaying or refusing a barrage of shots. What these […]
CDC Narrows RSV Vaccine Guidelines Due to Safety Concerns
The U.S. Centers for Disease Control and Prevention (CDC) has recently narrowed its original recommendations for the respiratory syncytial virus (RSV) vaccine, citing concerns over the risk of a side effect that can lead to paralysis or death. The recommendations originally stated adults over the age of 60 should receive the vaccine, but updates in […]
Reports of Eye Disorders Spike After COVID Shots
In 2021, the World Health Organization’s (WHO) European drug monitoring system known as Vigibase, maintained by the Uppsala Monitoring Centre (UMC) in Sweden, received 19,916 reports of eye disorders following administration of COVID-19 shots. Vigibase had never recorded such a big spike in eye disorders until these biologics were introduced into the European market.1 Eye […]
Guillain-Barré Syndrome ‘More Common Than Expected’ in Early RSV Vaccine Trial
Reports of the nervous system disorder Guillain-Barré syndrome (GBS) were “more common than expected” in the older adult population who received the new vaccine for respiratory syncytial virus (RSV). The data, reported by the U.S. Centers for Disease Control and Prevention (CDC), matched trial data reported earlier this year.1 GBS is a “polio-like” inflammatory autoimmune […]